The hardware and bandwidth for this mirror is donated by dogado GmbH, the Webhosting and Full Service-Cloud Provider. Check out our Wordpress Tutorial.
If you wish to report a bug, or if you are interested in having us mirror your free-software or open-source project, please feel free to contact us at mirror[@]dogado.de.

HhP: Hierarchical Heterogeneity Analysis via Penalization

In medical research, supervised heterogeneity analysis has important implications. Assume that there are two types of features. Using both types of features, our goal is to conduct the first supervised heterogeneity analysis that satisfies a hierarchical structure. That is, the first type of features defines a rough structure, and the second type defines a nested and more refined structure. A penalization approach is developed, which has been motivated by but differs significantly from penalized fusion and sparse group penalization. Reference: Ren, M., Zhang, Q., Zhang, S., Zhong, T., Huang, J. & Ma, S. (2022). "Hierarchical cancer heterogeneity analysis based on histopathological imaging features". Biometrics, <doi:10.1111/biom.13426>.

Version: 1.0.0
Depends: R (≥ 3.5.0)
Imports: MASS, Matrix, fmrs, methods
Suggests: knitr, rmarkdown
Published: 2022-11-23
DOI: 10.32614/CRAN.package.HhP
Author: Mingyang Ren ORCID iD [aut, cre], Qingzhao Zhang [aut], Sanguo Zhang [aut], Tingyan Zhong [aut], Jian Huang [aut], Shuangge Ma [aut]
Maintainer: Mingyang Ren <renmingyang17 at mails.ucas.ac.cn>
License: GPL-2
NeedsCompilation: no
CRAN checks: HhP results

Documentation:

Reference manual: HhP.pdf
Vignettes: HhP

Downloads:

Package source: HhP_1.0.0.tar.gz
Windows binaries: r-devel: HhP_1.0.0.zip, r-release: HhP_1.0.0.zip, r-oldrel: HhP_1.0.0.zip
macOS binaries: r-release (arm64): HhP_1.0.0.tgz, r-oldrel (arm64): HhP_1.0.0.tgz, r-release (x86_64): HhP_1.0.0.tgz, r-oldrel (x86_64): HhP_1.0.0.tgz

Linking:

Please use the canonical form https://CRAN.R-project.org/package=HhP to link to this page.

These binaries (installable software) and packages are in development.
They may not be fully stable and should be used with caution. We make no claims about them.
Health stats visible at Monitor.